87 results
Page 3 of 5
8-K
EX-99.1
5nhy1 r6gt
12 Nov 20
Hepion Pharmaceuticals to Present at The Liver Meeting Digital ExperienceTM 2020
9:33am
8-K
EX-99.1
59gz0af79ch1aa
5 Oct 20
Announces Creation of Clinical Pharmacology Analytics Team
9:06am
8-K
EX-99.1
g48d55p
1 Oct 20
Regulation FD Disclosure
4:27pm
8-K
EX-99.1
xe89nc43
12 Aug 20
Hepion Pharmaceuticals Announces Publication of Preclinical Study Evaluating CRV431’s Antiviral Properties
8:46am
8-K
EX-99.1
2cdebzdwq42u0j3ik16
15 Jun 20
Regulation FD Disclosure
9:22am
8-K
EX-99.1
rmk f4cv08bagpi1soa
19 May 20
Regulation FD Disclosure
9:51pm
424B5
ywos5spcxfo0fpzyoama
26 Mar 20
Prospectus supplement for primary offering
9:33pm
8-K
EX-99.1
pollb u3xu5337m
11 Mar 20
Regulation FD Disclosure
4:05pm
424B5
ac048nfe
12 Feb 20
Prospectus supplement for primary offering
9:05am
8-K
EX-99.1
2nr nmhp5k70
7 Feb 20
Regulation FD Disclosure
4:46pm
8-K
EX-99.1
mg075343wf2wecx4r94
9 Jan 20
Hepion Pharmaceuticals Presents Update on CRV431 Nonclinical Studies at NASH-TAG 2020 Conference
12:00am
8-K
EX-99.1
pvr4jqel 4e30
3 Dec 19
Regulation FD Disclosure
4:15pm
8-K
EX-99.1
ytvgqww vxb
8 Nov 19
Hepion Pharmaceuticals to Present at The Liver MeetingÒ 2019
12:00am
8-K
EX-99.1
2b1lhx
23 Oct 19
Hepion Pharmaceuticals to Present on CRV431 at the 3rd Annual NASH Summit
4:29pm